化工社化工社 化学情報印刷レポート · 研究参考用
Sodium Iodide → Aripiprazole
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Sodium Iodide | HCID 5238 | — |
| 反応物 | Acetonitrile | HCID 6342 | — |
| 反応物 | 1-(2,3-Dichlorophenyl)piperazine | HCID 851833 | — |
| 反応物 | 7-(4-bromobutoxy)-3,4-dihydro-2(1H)-quinolinone | HCID 10542064 | — |
| 溶媒 | Chloroform | HCID 6212 | — |
| 溶媒 | Triethylamine | HCID 8471 | — |
| 生成物 | Aripiprazole | HCID 60795 | 80.8% |
反応手順
A suspension of 47 g of 7-(4-bromobutoxy)-3,4-dihydrocarbostyril, 35 g of sodium iodide with 600 ml of acetonitrile was refluxed for 30 minutes. To this suspension was added 40 g of 1-(2,3-dichlorophenyl)piperazine and 33 ml of triethylamine and the whole mixture was further refluxed for 3 hours. After the solvent was removed by evaporation, the residue thus obtained was dissolved in chloroform, washed with water then dried with anhydrous magnesium sulfate. The solvent was removed by evaporation, and the residue thus obtained was recrystallized from ethanol twice, to yield 57.1 g of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08642760B2 |
| 出典データセット | uspto-grants-2014_02 |
| ORD ID | ord-a18fbd88147b417a889e11d3c18f357c |
| 出典メモ | uspto-grants-2014_02 |